Home ›
Organizations ›
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND
Medical Research · EIN 980407553
41
Executives Disclosed
$49.3M
Annual Revenue
$51.3M
Total Assets
1.9:1
Internal Pay Ratio
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND has 41 executives with disclosed compensation. The highest-paid executive, William Rodriguez (CHIEF EXECUTIVE OFFICER (thru 6/24)), received peak total compensation of $498,236. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| William Rodriguez | CHIEF EXECUTIVE OFFICER (thru 6/24) | $498K | $223K | 2022–2024 | 6.6x |
| Catharina Boehme | CHIEF EXECUTIVE OFFICER | $475K | $475K | 2020–2020 | 6.3x |
| Sergio Carmona | CHIEF MEDICAL OFFICER (thru 9/24) | $438K | $343K | 2020–2024 | 5.8x |
| Darryl English | DEPUTY DIRECTOR, FINANCE (THRU 11/24) | $414K | $414K | 2024–2024 | 5.5x |
| Marta Fernandez Suarez | CHIEF TECHNOLOGY OFFICER (thru 10/24) | $414K | $357K | 2021–2024 | 5.5x |
| Rangarajan Sampath | CHIEF SCIENTIFIC OFFICER | $405K | $405K | 2020–2020 | 5.4x |
| Louisa Chaubert | DIRECTOR OF FINANCE (THRU 12/23) | $358K | $103K | 2020–2024 | 4.8x |
| Cassandra Kelly-Cirino | VP, HEALTH PROGRAMMES (thru 8/24) | $334K | $236K | 2023–2024 | 4.4x |
| Willo Brock | EXECUTIVE VP, EXTERNAL AFFAIRS (thru 6/24) | $321K | $164K | 2023–2024 | 4.3x |
| Sharon Saacks | SENIOR DIRECTOR, PROGRAMME OPERATIONS (thru 7/24) | $315K | $269K | 2020–2024 | 4.2x |
| Beatrice Mouton | DIRECTOR, HUMAN RESOURCES | $313K | $313K | 2020–2024 | 4.2x |
| Morten Ruhwald | DIRECTOR, TUBERCULOSIS PROGRAMME | $310K | $299K | 2020–2024 | 4.1x |
| Emma Jane Hannay | CHIEF ACCESS OFFICER | $309K | $301K | 2021–2023 | 4.1x |
| Willo Brock Start 922 | VP,external Affairs | $302K | $302K | 2022–2022 | 4x |
| Brooke Nichols | SENIOR DIRECTOR, IMPACT | $297K | $297K | 2023–2024 | 4x |
| Daniel Bausch | SNR. ADVISOR CEO; GLOBAL HEALTH SEC (LEFT 11/23) | $292K | $269K | 2022–2023 | 3.9x |
| Shaukhat Ali Khan | Director Strategic Information | $290K | $290K | 2024–2024 | 3.9x |
| Stefano Ongarello | DIRECTOR, DATA SCIENCE | $285K | $285K | 2020–2023 | 3.8x |
| Sylvain Bieler | PRINCIPAL SCIENTIST | $279K | $279K | 2020–2023 | 3.7x |
| Loveday Sarah-Jane | Director, Communications | $262K | $262K | 2020–2021 | 3.5x |
| Willo Brock Start 321 | VP,external Affairs | $256K | $256K | 2021–2021 | 3.4x |
| Maria Cecilia Ferreyra Arellano | Director of AMR Programme | $250K | $250K | 2024–2024 | 3.3x |
| Cassandra Kelly | DIR. OF EMERGING THREAT | $244K | $244K | 2020–2020 | 3.3x |
| Anita Suresh | HEAD OF SEQUENCING | $241K | $241K | 2020–2020 | 3.2x |
| Sanjay Sarin | VP, ACCESS (thru 10/24) | $238K | $232K | 2021–2024 | 3.2x |
| Aditi Srinivasan | Director, Data Science | $234K | $234K | 2022–2022 | 3.1x |
| Norma Torres | CHIEF OPERATING OFFICER (thru 5/24) | $230K | $230K | 2023–2024 | 3.1x |
| Kevin Tetteh | DIRECTOR, MALARIA FEVER PROGRAMME | $225K | $225K | 2024–2024 | 3x |
| Sabine Dittrich | HEAD OF MALARIA & FEVER | $224K | $224K | 2020–2020 | 3x |
| Elena Ivanova | TECH. INNOVATION LEAD | $215K | $215K | 2020–2020 | 2.9x |
| Pamela Nabeta | SENIOR MANAGER QUAL/MED AFFAIR | $211K | $211K | 2020–2020 | 2.8x |
| William Rodriguez Start 721 | Chief Executive Officer | $209K | $209K | 2021–2021 | 2.8x |
| Joseph Ndung'u | HEAD NTD PROGRAM & FIND KENYA | $204K | $204K | 2020–2020 | 2.7x |
| Sonjelle Shilton | HEPATITIS LEAD | $199K | $199K | 2020–2020 | 2.7x |
| Hiedi Albert | HEAD OF SOUTH AFRICA FIND | $183K | $183K | 2020–2020 | 2.4x |
| Dayo Adetifa | CHIEF TRANSFORMATION OFFICER/CEO | $174K | $174K | 2024–2024 | 2.3x |
| Cassandra Kelly-Cirinostart922 | VP; Health Programmes | $97K | $0 | 2022–2022 | 1.3x |
| Catharina Boehme End 221 | CHIEF EXECUTIVE OFFICER | $95K | $0 | 2021–2021 | 1.3x |
| Jon Bastow | DIR. OF BUSINESS DEV. & RESOUR | $87K | $0 | 2020–2020 | 1.2x |
| Zachary Benjamin Katz | CHIEF ACCESS OFFICER | $77K | $0 | 2020–2020 | 1x |
| Rangarajan Sampath End 121 | CHIEF SCIENTIFIC OFFICER | $54K | $0 | 2021–2021 | 0.7x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2020 | 20 | $258K | $475K | $4.6M |
| 2021 | 15 | $282K | $438K | $3.7M |
| 2022 | 15 | $296K | $422K | $4.1M |
| 2023 | 16 | $316K | $498K | $5.1M |
| 2024 | 17 | $260K | $414K | $4.4M |
Email Alerts
Get notified about FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.